ZacharyReathSchoepflinMDPhD
Internal Medicine • Boston, MAHospital Medicine/Hospitalist, Hematology/Oncology
Clinical fellow in hematology/oncology at BIDMC
Dr. Schoepflin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 Brookline Ave
Boston, MA 02215Phone+1 617-667-7000
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2021 - 2025- Beth Israel Deaconess Medical CenterChief Residency, Internal Medicine, 2022 - 2023
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2018 - 2021
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2018
Certifications & Licensure
MA State Medical License 2018 - 2026- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 48 citationsCCN2 Suppresses Catabolic Effects of Interleukin-1β through α5β1 and αVβ3 Integrins in Nucleus Pulposus Cells: IMPLICATIONS IN INTERVERTEBRAL DISC DEGENERATIONCassie M. Tran, Zachary R. Schoepflin, Dessislava Markova, Christopher K. Kepler, D. Greg Anderson
The Journal of Biological Chemistry. 2014-03-14 - 246 citationsDisc in flames: Roles of TNF-α and IL-1β in intervertebral disc degeneration.Zariel I. Johnson, Zachary R. Schoepflin, Hyowon Choi, Irving M. Shapiro, Makarand V. Risbud
European Cells & Materials. 2015-09-21 - 24 citationsPHD3 is a transcriptional coactivator of HIF-1α in nucleus pulposus cells independent of the PKM2-JMJD5 axis.Zachary R. Schoepflin, Elizabeth S. Silagi, Irving M. Shapiro, Makarand V. Risbud
FASEB Journal. 2017-05-11
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
